Similar articles

• Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

  Kunkler I. Kunkler I. J Natl Cancer Inst. 2005 Aug 3;97(15):1162-3; author reply 1163-4. doi: 10.1093/jnci/dji216. J Natl Cancer Inst. 2005. PMID: 16077078 No abstract available.
• Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.

  Taghian AG, Jeong JH, Mamounas EP, Parda DS, Deutsch M, Costantino JP, Wolmark N. Taghian AG, et al. J Clin Oncol. 2006 Aug 20;24(24):3927-32. doi: 10.1200/JCO.2006.06.9054. J Clin Oncol. 2006. PMID: 16921044
• ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast.

  Taylor ME, Haffty BG, Rabinovitch R, Arthur DW, Halberg FE, Strom EA, White JR, Cobleigh MA, Edge SB. Taylor ME, et al. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):997-1002. doi: 10.1016/j.ijrobp.2008.10.080. Int J Radiat Oncol Biol Phys. 2009. PMID: 19251087 Review.
• The use of radiotherapy after mastectomy: a review of the literature.

  Pierce LJ. Pierce LJ. J Clin Oncol. 2005 Mar 10;23(8):1706-17. doi: 10.1200/JCO.2005.08.109. J Clin Oncol. 2005. PMID: 15755979 Review. No abstract available.
• More evidence that locoregional radiation therapy improves survival: what should we do?

  Whelan T, Levine M. Whelan T, et al. J Natl Cancer Inst. 2005 Jan 19;97(2):82-4. doi: 10.1093/jnci/djh328. J Natl Cancer Inst. 2005. PMID: 15657332 No abstract available.